If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company ...

The autopsy will be unhelpful in primary electrical diagnoses such as long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome, etc. 1 Hypertrophic ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...

Fintel reports that on December 13, 2024, Guggenheim downgraded their outlook for Boundless Bio (NasdaqGS:BOLD) from Buy to ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the ...

Wedbush began coverage on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a research note issued to investors on ...

A HEARTBROKEN family have paid tribute to their “vibrant” daughter, 20, who died suddenly. Poppy Eagle, from Washington, in ...

1 Department of Cardiology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China 2 Department of Emergency, Shenzhen Second People's Hospital, The ...